Vasundhara Rasy.

29
Strong Sell
  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE406F01010
  • NSEID:
  • BSEID: 538634
INR
156.95
5.55 (3.67%)
BSENSE

Jan 20

BSE+NSE Vol: 502

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationProfit and Loss Results
Results Snapshot
Figures in Cr
Standalone - Profit And Loss Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Profit And Loss Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Mar 2025 is -8.18% vs -2.43% in Mar 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2025 is -36.08% vs 15.73% in Mar 2024

stock-summary

Interest

YoY Growth in year ended Mar 2025 is 57.56% vs -13.83% in Mar 2024

stock-summary

Profit After Tax

YoY Growth in year ended Mar 2025 is -27.53% vs 4.80% in Mar 2024

Compare Profit and Loss Results of Vasundhara Rasy.
Markets Mojo
Figures in Cr
standalone - Profit And Loss Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
No of Months
12
12
Operating Income
33.00
24.00
9.00
37.50%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
33.00
24.00
9.00
37.50%
Expenditure (Ex Depriciation)
Stock Adjustments
0.00
-143.00
143.00
100.00%
Raw Materials Consumed
15.00
164.00
-149.00
-90.85%
Power & Fuel Cost
0.00
0.00
0.00
0%
Employee Cost
3.00
0.00
3.00
0%
Operating Expenses
3.00
0.00
3.00
0%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
1.00
0.00
1.00
0%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
0.00
0.00
0.00
0%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
29.00
23.00
6.00
26.09%
Operating Profit (PBDIT) excl Other Income
4.00
0.00
4.00
0%
Other Income
2.00
1.00
1.00
100.00%
Operating Profit (PBDIT)
6.00
2.00
4.00
200.00%
Interest
0.00
0.00
0.00
0%
Profit before Depriciation and Tax
6.00
2.00
4.00
200.00%
Depreciation
0.00
0.00
0.00
0%
Profit Before Taxation & Exceptional Items
5.00
2.00
3.00
150.00%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
5.00
2.00
3.00
150.00%
Provision for Tax
1.00
0.00
1.00
0%
Profit After Tax
4.00
2.00
2.00
100.00%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
28.00
-12.00
40.00
333.33%
Profit Available for appropriations
32.00
-10.00
42.00
420.00%
Appropriations
32.00
-10.00
42.00
420.00%
Equity Dividend (%)
20%
0%
20.00
Earnings Per Share
13.36
0.36
13.00
3,611.11%
Profit And Loss - Net Sales
Net Sales 33.99 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is -8.18% vs -2.43% in Mar 2024

Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 4.11 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is -36.08% vs 15.73% in Mar 2024

Profit And Loss - Interest
Interest 0.34 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 57.56% vs -13.83% in Mar 2024

Profit And Loss - Profit After Tax
Profit After Tax 4.25 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is -27.53% vs 4.80% in Mar 2024